You have access
Adverse Events Associated With Long-term Treatment of Epithelial Ovarian Cancer With Bevacizumab and Chemotherapy
YUKA YOKOYAMA, MICHIKO KUBO-KANEDA, KIMI SUNADA, YASUHIRO TEISHIKATA, ASA KITAMURA, KOTA OKAMOTO, KUNIAKI TORIYABE, MASAFUMI NII, KENTA YOSHIDA, EIJI KONDO and TOMOAKI IKEDA
Anticancer Research August 2022, 42 (8) 4165-4171; DOI: https://doi.org/10.21873/anticanres.15916